CHRU de Brest

Running trials

• Recruiting

  A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  NCT07174336· Phase 3· Source

• Recruiting

  A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  NCT07218380· Phase 3· Source

• Recruiting

  A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  NCT07213804· Phase 3· Source

• Recruiting

  A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

  NCT07219173· Phase 2· Source

• Recruiting

  Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

  NCT07106762· Phase 2/3· Source

• Recruiting

  Rheopheresis as Adjuvant Treatment of Calciphylaxis

  NCT04654000· Source

• Recruiting

  Prospective Cohort of Patients With Systemic Sclerosis at Brest University Hospital With Biobanking

  NCT05532865· Source

• Active, not recruiting

  Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer

  NCT05169567· Phase 3· Source

• Recruiting

  Retrospective Observational Study on Prediction of Response to PD-1 Immunotherapy in Patients with NSCLC

  NCT04886401· Source

• Active, not recruiting

  PRediction Of DIverse Glucocorticoids toxIcity OUtcomeS

  NCT04664465· Source

• Recruiting

  Systemic Lupus Erythematosus Within the Framework of the Multidisciplinary Consultation

  NCT04320680· Source

• Recruiting

  Follow-up of the Systemic Lupus Erythematosus Cohort as Part of the Multidisciplinary Consultation at Brest CHRU

  NCT06551389· Source

• Active, not recruiting

  Prostate-cancer Treatment Using Stereotactic Radiotherapy for Oligometastases Ablation in Hormone-sensitive Patients

  NCT04115007· Phase 3· Source

• Recruiting

  B-dependant Rare AutoImmune diseaSES - Cohort of Patients With Suspected Diagnosis of Primitive Sjögren Syndrome

  NCT04931160· Source

• Recruiting

  French Colorectal ESD Cohort in Experts Centers

  NCT04592003· Source

• Active, not recruiting

  Comparison of Intermittent Androgen Deprivation Therapy With or Without Irradiation Recovery in Prostate Cancer Patients

  NCT03630666· Source

• Recruiting

  Semantic and Syntactic Computerized Analysis of Free Speech

  NCT03525054· Source

• Active, not recruiting

  Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO)

  NCT03496402· Source

• Active, not recruiting

  PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer

  NCT03774732· Phase 3· Source

• Recruiting

  Population-based Brest Stroke Registry

  NCT02900521· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Bladder cancer2 recruiting
• Lupus (SLE)2 recruiting
• Asthma1 recruiting
• Childhood cancers1 recruiting
• Chronic kidney disease1 recruiting
• Colorectal cancer1 recruiting
• Lung cancer1 recruiting
• Metastatic breast cancer1 recruiting
• Ovarian cancer1 recruiting
• Rheumatoid arthritis1 recruiting
• Schizophrenia1 recruiting
• Sjögren's disease1 recruiting
• Stroke1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis

  NCT05642208· Phase 4· Source

• Completed

  Virtual Reality for the Mitigation of Anxiety During Intrathecal Administration in Participants With Spinal Muscular Atrophy

  NCT05354414· Source

• Terminated

  Diagnostic Performance of PSMA PET/CT for Pre-operative Lymph Node Assessment in Intermediate and High-risk Non-metastasic Prostate Cancer (PREOP-PSMA ).

  NCT04745871· Source

• Completed

  Mobile Technologies and Post-stroke Depression

  NCT04043052· Source

• Completed

  Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

  NCT02003924· Phase 3· Source

• Completed

  Radical Versus Simple Hysterectomy and Pelvic Node Dissection With Low-risk Early Stage Cervical Cancer

  NCT01658930· Source